ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
Changes to Medicare Part B payment for lab tests mandated by the Protecting Access to Medicare Act of 2014 (PAMA) take effect on…
From - Laboratory Industry Report
The U.S. Drug Enforcement Administration's latest National Take-Back Initiative happens this month on Oct. 22, when the public is…
From - Laboratory Industry Report
As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to…
From - Laboratory Industry Report
Provista Diagnostics, a New York City-based molecular laboratory has concluded that the age of patients can play a role in the…
From - Laboratory Industry Report
Quest Diagnostics has introduced a product that is a departure from the typical laboratory test but is expected to assist…